Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Hyperglycemia × CNS × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 CNS 1

Conditions

Brain Neoplasms 89 Glioblastoma 76 Glioma 49 Central Nervous System Neoplasms 29 Neuroblastoma 26 Astrocytoma 26 Breast Neoplasms 18 Oligodendroglioma 17 Gliosarcoma 17 Neoplasms 15 Recurrence 12 Medulloblastoma 12 Neoplasm Metastasis 11 Ependymoma 11 Carcinoma, Non-Small-Cell Lung 9 Sarcoma 8 Osteosarcoma 8 Lymphoma 8 Neuroma, Acoustic 7 Meningioma 7 Wilms Tumor 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neuroectodermal Tumors, Primitive 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Hodgkin Disease 6 Burkitt Lymphoma 6 Sezary Syndrome 5 Rhabdomyosarcoma 5 Mycosis Fungoides 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03235934 2021-10-25

Glycemic Impact on Glioblastoma Outcomes

University Health Network, Toronto

Glioblastoma, Hyperglycemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡